USD 63.20
Price
-0.60
(-0.94%)
Day Change
|
|
---|
AZN, the overall quality is very good (Quality = 85) but the timing to buy is ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROA is too relatively low compare to ROE
Historical net profit margin is relatively low.
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is ok , ...
Quality Factors |
|
50% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.00 From 30 days period |
Social Score | 10 |
Magic Formula Rank by ROA |
1615
|
Magic Formula Rank by ROE |
1615
|
Magic Formula Rank by ROIC |
1824
|
Price | 63.20 |
PBV / Sector |
2.43 / 11.36
|
Earning Per Share | 2.07 |
PE / Sector |
30.62 / 31.00
|
PEG or PE/Growth / Sector |
0.68 / 1.34
|
Average 1M Daily Value |
538.84 M
|
Average 1W Daily Value |
495.20 M
GREAT
|
Timing Factors |
|
28% |
Financial Health |
|
50% |
Ability to Make Profit |
|
62% |
Return to Investors |
|
12% |
Registration Details |
Analyze Date | 2024-11-20 19:59:38 |
Symbol | AZN |
Name | ASTRAZENECA PLC ADR |
Sector | Healthcare >> Drug Manufacturers - General |
Market | NASDAQ |
Listed Shares | 3,100.61 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 196,547.67 / 213,940.23 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |